(Q53290887)

13 May 2018

title

Predictors of cognitive impairment and dementia in older people with diabetes. (English)

1 reference

13 May 2018

main subject

dementia

0 references

cognitive dysfunction

1 reference

1

1 reference

13 May 2018

Sergio E. Starkstein

4

object named as

S E Starkstein

1 reference

13 May 2018

author name string

W A Davis

2

1 reference

13 May 2018

G P Casey

3

1 reference

13 May 2018

R M Clarnette

5

1 reference

13 May 2018

J K Foster

6

1 reference

13 May 2018

O P Almeida

7

1 reference

13 May 2018

T M E Davis

8

1 reference

13 May 2018

publication date

5 December 2007

1 reference

13 May 2018

published in

Diabetologia

1 reference

13 May 2018

volume

51

1 reference

13 May 2018

page(s)

241-248

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/s00125-007-0894-7

exact match

0 references

cites work

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

Midlife cardiovascular risk factors and risk of dementia in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

Diabetes, impaired fasting glucose, and development of cognitive impairment in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

Glycemic control in older subjects with type 2 diabetes mellitus in the Fremantle Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

The incidence of dementia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

Social and leisure activities and risk of dementia: a prospective longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-007-0894-7

Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging

21 January 2018

1 reference

12 December 2020

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

1 reference

12 December 2020

The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease

1 reference

12 December 2020

Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study

1 reference

12 December 2020

Adiposity indices and dementia

1 reference

12 December 2020

Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study

1 reference

12 December 2020

Alzheimer disease as a vascular disorder: nosological evidence

1 reference

12 December 2020

Five-Year Follow-up of Cognitive Impairment With No Dementia

1 reference

12 December 2020

The effect of borderline diabetes on the risk of dementia and Alzheimer's disease

1 reference

12 December 2020

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

1 reference

12 December 2020

Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.

1 reference

12 December 2020

Atherosclerosis and risk for dementia

1 reference

12 December 2020

Progress in cardiovascular diseases: cognitive function in essential hypertension

1 reference

12 December 2020

A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation.

1 reference

12 December 2020

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

1 reference

12 December 2020

Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies

1 reference

12 December 2020

A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study

1 reference

12 December 2020

1 reference

12 December 2020

Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease

1 reference

12 December 2020

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

1 reference

12 December 2020

Molecular connexions between dementia and diabetes.

1 reference

12 December 2020

The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations

1 reference

12 December 2020

HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study

1 reference

12 December 2020

Determinants of diabetes-attributable non-blood glucose-lowering medication costs in type 2 diabetes: the Fremantle Diabetes Study

1 reference

12 December 2020

Mild impairments in cognition in patients with type 2 diabetes mellitus: the use of the concepts MCI and CIND.

1 reference

12 December 2020

Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.

1 reference

12 December 2020

Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort.

1 reference

12 December 2020

Vascular depression in older people with diabetes.

1 reference

12 December 2020

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

1 reference

12 December 2020

Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study.

1 reference

12 December 2020

10.1007/S00125-007-0894-7

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

18060658

1 reference

13 May 2018